← FDA Drug Approvals (Drugs@FDA)

ALYMSYS

BLA · Biologics License Application · Sponsor: AMNEAL PHARMS LLC · Approved 2022-04-13

Drug application

FDA Application #

BLA761231

Application type

Biologics License Application

Brand name

ALYMSYS

Generic name

BEVACIZUMAB-MALY

Active ingredients

BEVACIZUMAB-MALY

Dosage form

INJECTABLE

Route

INJECTION

Marketing status

Prescription

Sponsor

AMNEAL PHARMS LLC

Manufacturer

Amneal Pharmaceuticals LLC

First approval

2022-04-13

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown